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Abstract
The use of alcohol and other drugs (AODs) is an important driver of gender disparities in HIV 
prevalence. Consequently, there is a need for women-specific HIV interventions that are 
conceptualized to address (1) women’s risk behavior, their roles in sexual relationships, and 
gender power dynamics, and (2) other issues commonly faced by women who use AODs, such as 
gender-based violence and victimization. This article presents the evolution of HIV prevention 
intervention research with women who use AODs. It looks at three generations of women-focused 
HIV research interventions, including first-generation projects that started in the 1990s, second-
generation efforts where projects expanded in scope and included adaptions of evidence-based 
interventions for global relevance, and finally third-generation projects currently underway that 
combine biobehavioral methods and are being implemented in real-world settings. Because 
women who use AODs continue to report risk behaviors related to HIV, emphasis should be 
placed on training scientists to conduct gender-specific studies, increasing funding for new 
studies, and advocating to ensure that stigma-free services are available for these at-risk women.
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Introduction
The use of alcohol and other drugs (AODs) is an important driver of gender disparities in 
HIV prevalence. Research has shown that alcohol as well as other drug use among women 
leads to disinhibition and impaired judgment that may result in inconsistent condom use and 
other risky sex behaviors.1,2 AOD-using women may engage in unsafe sex practices, such as 
trading sex in exchange for AODs (or money to buy AODs) for themselves or their sex 
partners1,3–5 or they may use AODs to cope with sex trading.6,7 In such exchanges, women 
have limited agency to negotiate condom use and other preventive behaviors, especially if 
they are under the influence of AODs.6,8 This puts AOD-using women at high risk of 
contracting HIV and other sexually transmitted infections (STIs).9–13 Furthermore, women 
who inject drugs lack agency in negotiating safer injection practices with injecting sex 
partners, increasing the possibility of contracting HIV.14,15 Gender differences in injection 
practices also increases HIV risk among women who inject drugs. For example, women are 
more likely to use works (injection equipment) after men, which increases their chance of 
exposure to HIV.16
Women who use AODs are at especially high risk for heterosexual transmission of HIV, as 
they are often in sexual relationships with men who use AODs and who also participate in 
high-risk behaviors.17 In addition, compared with men, women are more biologically 
susceptible to HIV through sexual transmission.18 Accordingly, these intersecting risk 
behaviors associated with AOD use among women translate into greater gender disparities 
in HIV. Other contextual and structural factors also impact women’s risk for HIV. For 
instance, women who use AODs often have histories of abuse and experience intimate 
partner violence.3,6,19,20 There is strong evidence that experiences of partner abuse and 
gender-based violence are directly associated with HIV risk among women.21 Furthermore, 
women who use AODs and live in cultural contexts where men have all the decision-making 
power and are in control of the financial resources may lack the agency to negotiate 
protective behaviors, augmenting their risk for HIV and other diseases.22
Despite the significant need for women-specific preventive and reproductive healthcare 
among this highly vulnerable population, when women who use AODs seek health services 
they are often stigmatized, discriminated against, and treated poorly.23–26 In other instances, 
they are ignored, given incorrect information, and disrespected by staff, which discourages 
them from seeking services.27,28 Moreover, when women do seek services, many facilities 
do not offer childcare, clinic hours are inconvenient, and waiting times are long.29,30 All of 
these factors have been identified as barriers to seeking and initiating health and AOD 
treatment services.31,32 These barriers contribute to gender disparities in health outcomes 
among women who use AODs, with a recent study reporting substantially higher mortality 
rates among female drug users in Central Asia compared with their male counterparts.33
Wechsberg et al. Page 2













Despite these gender disparities in HIV risk and health outcomes, early HIV prevention 
intervention studies did not focus exclusively on AOD-using women and their unique needs, 
and it took a generation of HIV interventions before women-focused approaches to HIV 
prevention began to emerge.34,35 Whether all HIV prevention approaches for women who 
use AODs should be gender- and women-specific can be debated, given that policy, fiscal, 
cultural, and training resources can be a challenge and overall risk-reduction among both 
men and women must be considered foremost. Although the terms gender-specific and 
women-focused may have different meanings when speaking about single-sex interventions, 
they are used interchangeably in the literature. In this article, we focus on women-focused 
HIV interventions that are conceptualized to address (1) women’s risk behavior, roles in 
sexual relationships, and gender power dynamics, and (2) other issues commonly faced by 
many women, such as gender-based violence and victimization.
Substantial progress has occurred in the development of women-focused behavioral HIV 
prevention interventions over the past couple of decades, as National Institute on Drug 
Abuse (NIDA) sponsored intervention research has aimed to reach hard-to-reach and 
vulnerable AOD-using women at risk for HIV. In the past decade there has been an 
increasing emphasis on evidence-based approaches to behavioral prevention of HIV. 
However, there are still relatively few evidence-based HIV prevention interventions globally 
for women who use AODs.36 For example, out of 84 evidence-based behavioral risk-
reduction interventions listed on the US Centers for Disease Control’s Compendium of 
Evidence-Based Interventions and Best Practices for HIV Prevention, only three are 
specifically designed for women who use AODs,13,37,38 and one is listed for couples who 
use AODs.39 Nonetheless, women-focused interventions and their components have evolved 
as the science has advanced.
The evolution of women-focused HIV prevention interventions
Historically, there have been three generations of women-focused HIV prevention 
interventions (see Table 1). The first-generation HIV interventions, implemented in the 
1990s, were pioneering in their efforts. All of the first-generation HIV interventions were 
conducted in the United States and have evolved over time. Most of the first-generation HIV 
prevention interventions for women targeted HIV/AIDS knowledge and increasing condom 
use, and only one was specifically for women of color.40 While these first-generation 
interventions addressed HIV risk, they did not address the other contextual factors that 
influence a woman’s ability to take protective action and reduce sex risk behavior, such as 
gender-based violence and female empowerment. Some of the early interventions funded by 
NIDA in the United States that targeted women who inject drugs, crack cocaine smokers, 
and sex partners of men who inject drugs did include components on negotiating condom 
use without risking partner and gender-based violence.41 These were usually delivered in a 
women-only session, but they did not occur in the context of a larger gender-specific 
intervention.
Beginning in 2000, a number of HIV interventions were expanded to contain culturally 
sensitive, women-specific content addressing contextual influences on risk behaviors or to 
include economic enhancement strategies, based on the recognition of the importance of 
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interventions tailored for the unique needs of women.42,43 These second-generation HIV 
interventions advanced the first-generation interventions by also addressing a range of 
contextual factors (e.g., gender-based violence, homelessness, employment, female 
empowerment) that impede or facilitate women’s ability to implement HIV prevention 
strategies. Many of these second-generation interventions involved adaptations of the first-
and second-generation interventions and several expanded to countries outside of the United 
States. They also began to focus on subgroups of vulnerable women, such as sex workers 
and currently or recently incarcerated women. Some had been adapted for couples who use 
AODs.
Around 2010, third-generation interventions emerged. These interventions added biomedical 
components to the behavioral intervention base of the second-generation interventions. For 
example, they provide antiretroviral therapy (ART) to women living with HIV to reduce 
infectiousness and pre-exposure prophylaxis (PrEP) to serodiscordant partners.
This article provides a historical review of each generation of women-focused HIV 
interventions, explores the challenges to delivering these interventions, and discusses 
directions in which these interventions need to develop to better prevent HIV among women 
who use AODs.
Methods
We worked with a professional reference librarian to develop a search strategy. Once we had 
a satisfactory search strategy, the librarian conducted searches on Medline via PubMed, 
Embase, and ISI Web of Science for articles and abstracts related to substance use and HIV 
prevention interventions for women that had been published since 1990. The search strategy 
is shown in Appendix 1. Searches were conducted between November 2014 and January 
2015. All searches were limited to English-language articles only. We conducted separate 
searches for women-specific interventions and interventions for AOD-using heterosexual 
couples as gender-specific interventions involving women. To supplement this search 
strategy, we sent out a request for additional articles over the International Women’s and 
Children’s Health and Gender Group (InWomen’s) listserv.44 This group includes many of 
the researchers who conduct gender-specific HIV prevention intervention studies. Although 
we made our search as comprehensive as possible, we did not conduct a formal systematic 
review, which would have involved searching all conference abstracts and contacting 
authors of unpublished manuscripts. The combined searches returned 680 results, with 203 
duplicated results.
To be included in this review, articles had to report on a randomized controlled trial of a 
women-focused HIV prevention intervention; target AOD-using women; and report on at 
least one of the following outcomes—(a) sex risk behaviors, including condom skills, (b) 
injection risk behaviors, (c) HIV incidence, or (d) AOD use. We reviewed the abstracts 
generated by the search and subsequently obtained copies of all manuscripts that clearly met 
the inclusion criteria. We also obtained manuscripts for all cases where the information in 
the abstract was insufficient to make a determination.
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The most common reasons for exclusion were that the article did not report on an 
intervention (n=304), the intervention was not gender-specific (n=33), the intervention did 
not focus on women who use AODs (n=29), and the article did not report on our specified 
outcomes (n=46). A total of 23 studies met the inclusion criteria (see Appendix 2).
Results
Our search identified four first-generation interventions, all of which were conducted in the 
late 1980s and early 1990s. These interventions helped to establish the feasibility and 
acceptability of women-focused interventions for women who use AODs. All but one these 
interventions reported efficacy on at least one of the outcomes of interest. These studies also 
provided initial evidence that interventions may be efficacious in reducing HIV risk among 
vulnerable women. As such, these first-generation interventions laid the foundation for the 
next generation of interventions to follow.
We identified 19 interventions that met the criteria for second-generation women-focused 
interventions for women who use AODs, which also included couple-focused interventions 
for couples who used AODs. Among these 19 second-generation interventions, 11 were 
tested in studies conducted in the United States and 8 were tested in other countries, 
including Mexico, Mongolia, Russia, and South Africa. Sex risk reduction was a specific 
focus of 18 of the second-generation interventions; 14 included a focus on reducing AOD 
use; 4 included activities to reduce injection risk; and 6 included activities to reduce risk of 
victimization. All but two studies found efficacy in the women-focused arm. The second-
generation interventions developed newer methods and innovations, such as computerized 
instrumentation, multimedia components and video storytelling, and microeconomics.45 A 
detailed description of these first- and second-generation interventions and their outcomes is 
presented in Tables 2 and 3, respectively.
The emerging third-generation interventions are starting to take a combination prevention 
approach that incorporates a biomedical component in addition to the behavioral risk-
reduction foundation.46 Several third-generation interventions are currently being tested, and 
while some of their research protocols are available, no outcomes have been published 
yet.46,47
Discussion
Although the first-generation HIV interventions for women who use AODs provided 
evidence of initial efficacy in reducing behavioral risks for HIV among women who use 
AODs, many women who received them continued to use AODs, engage in sex without a 
condom, and be exposed to gender-based violence. The second-generation interventions 
advanced to address additional contextual issues for risk-reduction strategies; however, risk 
behavior continued even with these advances. Other more recent second-generation 
interventions that address structural factors (e.g., organizational components) have the 
potential to overcome risk at multiple levels and additional barriers, which will empower 
women to further reduce their risk. The third-generation interventions, which include 
Wechsberg et al. Page 5













biomedical prevention strategies (e.g., ART and PrEP) have the potential to protect women 
from HIV even when they are unable to negotiate condom use.46
Globally, women who use AODs are still a key population at risk for HIV and they need to 
be reached for HIV prevention interventions using evidence-based, gender-specific 
programs. Second-generation efforts to prevent HIV among women in different regions have 
led to various intervention adaptations to ensure that they are culturally congruent (e.g., 
language, drug type) and that they target the most relevant risk behaviors (e.g., injecting vs. 
noninjecting risks). Throughout this evolutionary process, reducing sexual risks has been the 
centerpiece of interventions to help women reduce their risks for HIV.
Most behavioral interventions that work with individuals or small groups tend to emphasize 
risk elimination among participants. However, risk elimination is not necessary for an 
intervention to have a major impact at the population level. Predictive simulation models 
suggest that reducing transmission risk below a certain threshold can have a major impact on 
an HIV epidemic even in the context of continued risk at reduced levels.48,49 In most 
settings, women-focused interventions will be implemented as part of a comprehensive HIV 
prevention package. A variety of harm-reduction activities might include condom 
distribution, scaled-up HIV testing, HIV services, opiate substitution, and syringe exchanges 
(for injectors). As noted previously, AOD-using women contribute disproportionately to 
HIV epidemics, so women-focused interventions for AOD-using women must be included 
in comprehensive HIV prevention packages if these efforts are to achieve maximum success.
Harm reduction to reduce risk but not totally eliminate all risk represents important progress. 
The second-generation interventions expanded to incorporate the complex risk environments 
of women who use AODs; addressing gender roles, power dynamics in relationships, 
gender-based violence, and couple relationships.39,5051 Our literature search, which spanned 
25 years, only identified about two dozen gender-specific interventions for women who use 
AODs; with even fewer implemented in real-world settings. Yet globally, women bear an 
increasing proportion of the burden of HIV, which is disproportionately concentrated among 
women who use AODs. Consequently, capitalizing on these gains is essential.
Despite the scientific advances with gender-specific HIV interventions for women who use 
AODs, multiple challenges exist in real-world settings for facilitating broader 
implementation and ensuring sustainability. For example, there is a scarcity of resources for 
behavioral and biomedical gender-specific studies for populations that use AODs, and to test 
and implement interventions. Also, the limited number of women-focused and gender-
specific studies indicates the low priority given to interventions for women, which may also 
reflect larger societal gender injustices. Furthermore, expanding efforts to develop women-
specific and gender-specific HIV interventions will necessitate recruiting and training more 
investigators, especially with an international focus, who are committed to gender research. 
This will require additional funding resources for mentoring to increase understanding and 
empathy about the unique needs of vulnerable and at-risk women and the risk environment 
in which they live.52
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Another resource challenge relates to the lack of funding for the combination of biomedical 
and behavioral interventions for women who use AODs. For example, it is important to test 
interventions that incorporate PrEP into behavioral interventions with serodiscordant 
couples who use AODs, which will require additional funding. More research is needed to 
examine service access as well the shortage of antiretrovirals and clinic staff in some 
regions. In many settings, the overall healthcare system is already overburdened, which 
reduces the likelihood of studying or implementing these efforts without additional funding.
As shown in this review, a number of women-focused interventions have demonstrated 
efficacy in reducing HIV risk among women who use AODs. Efforts are now needed to 
move these efficacious interventions into real-world practice settings and to make them even 
more efficacious and effective. In addition to the resource challenges described above, there 
are multiple challenges to implementation and service development, especially related to 
gender-specific programming. The Consolidated Framework for Implementation Research 
(CFIR), which examines characteristics of the interventions, the characteristics of the 
women themselves, the social setting, and the structural setting for service impact on 
intervention implementation,53 provides an approach to identifying potential challenges in 
implementing these interventions so that these can be addressed during the implementation 
process.
It is also important to note that we did not identify any interventions that addressed 
sociostructural barriers such as stigma, discrimination, and marginalization from health 
services that prevent AOD-using women from accessing HIV prevention and treatment 
services. Consequently, while the third-generation HIV interventions for women who use 
AODs can incorporate new biobehavioral advances in prevention, barriers to 
implementation of evidence-based programing as well as structural barriers to women’s 
utilization of these programs are likely to continue, and they must be studied and addressed 
to be fully beneficial for women who use AODs. Also, research must be coupled with 
advocacy to increase funding and implementation, and to bring needed changes in service 
delivery.
Limitations
Several limitations to this review should be noted. First, only randomized trials published in 
peer-reviewed journals were included. Consequently, women-focused studies that 
demonstrated efficacy but were only presented at conferences or appeared in the gray 
literature, for example, were not included. Second, more studies with null findings may have 
been conducted, but because of publication bias, they were not published and are not 
included in this review. Third, although we used a structured search strategy, we did not 
conduct a formal systematic review or meta-analysis, which limits some of our conclusions. 
Fourth, this review was limited to English-language articles.
Conclusions
A number of women-focused interventions have been found to be efficacious for reducing 
HIV-related risk and associated behaviors. The future of women-focused, gender-specific, 
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and couples’ interventions lies in the ability to translate them to real-world settings and to 
populations where they are most needed using sustainable implementation strategies. 
Ensuring that research findings move to policy and practice and that efficacious programs 
are disseminated and maintained is a global challenge. To eradicate new HIV infections 
among women, we will need a universal commitment and sufficient resources to address 
gender and its relationship to the intersecting behaviors associated with HIV through AOD 
use and contextual disparities.
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Appendix 1. Search Strategy
We searched Pubmed, Embase, and Web of Science using the following search terms.
(("HIV Infections/prevention and control"[Mesh] OR "Acquired Immunodeficiency Syndrome/prevention and 
control"[Mesh] OR HIV*[Title] OR "Acquired Immunodeficiency Syndrome"[Title] OR "Human Immunodeficiency 
Virus"[Title]) AND (("Female"[Mesh] NOT "Male"[Mesh]) OR "Women"[Mesh] OR "Women's Health"[Mesh] OR 
"Women's Health Services"[Mesh] OR female*[Title] OR girl*[Title] OR women*[Title] OR woman*[Title]) AND 
("Substance-Related Disorders"[Mesh] OR "Street Drugs"[Mesh] OR "Alcohol Drinking"[Mesh] OR "Heroin"[Mesh] 
OR "Cocaine"[Mesh] OR "Designer Drugs"[Mesh] OR "Marijuana Smoking"[Mesh] OR "Alcoholic Beverages"[Mesh] 
OR substance abus*[Title] OR substance us*[Title] OR alcohol*[Title] OR "drinking"[Title] OR drug abus*[Title] OR 
drug us*[Title] OR illegal drug*[Title] OR "heroin"[Title] OR "cocaine"[Title] OR "marijuana"[Title]) AND 
("Intervention Studies"[Mesh] OR "Risk Reduction Behavior"[Mesh:NoExp] OR "Health Education"[Mesh] OR 
"Health Promotion"[Mesh] OR "Program Evaluation"[Mesh] OR "Preventive Health Services"[Mesh] OR 
intervention*[Title] OR program*[Title] OR risk reduc*[Title] OR prevent*[Title] OR educat*[Title] OR "health 
promotion"[Title])) Publication date from 1990/01/01; English
OR
(("HIV Infections/prevention and control"[Mesh] OR "Acquired Immunodeficiency Syndrome/prevention and 
control"[Mesh] OR HIV*[Title] OR "Acquired Immunodeficiency Syndrome"[Title] OR "Human Immunodeficiency 
Virus"[Title]) AND ("Spouses"[Mesh] OR "Marriage"[Mesh] OR "Sexual Partners"[Majr] OR "couple"[Title] OR 
"couples"[Title] OR "partner"[Title] OR "partners"[Title] OR "married"[Title] OR marriage*[Title] OR significant 
other*[Title] OR husband*[Title] OR "wives"[Title] OR "wife"[Title] OR boyfriend*[Title] OR girlfriend*[Title] OR 
boy friend*[Title] OR girl friend*[Title] OR relationship*[Title] OR "dating"[Title] OR lover*[Title] OR spous*[Title] 
OR romantic*[Title]) AND ("Substance-Related Disorders"[Mesh] OR "Street Drugs"[Mesh] OR "Alcohol 
Drinking"[Mesh] OR "Heroin"[Mesh] OR "Cocaine"[Mesh] OR "Designer Drugs"[Mesh] OR "Marijuana 
Smoking"[Mesh] OR "Alcoholic Beverages"[Mesh] OR substance abus*[Title] OR substance us*[Title] OR 
alcohol*[Title] OR "drinking"[Title] OR drug abus*[Title] OR drug us*[Title] OR illegal drug*[Title] OR 
"heroin"[Title] OR "cocaine"[Title] OR "marijuana"[Title]) AND ("Intervention Studies"[Mesh] OR "Risk Reduction 
Behavior"[Mesh:NoExp] OR "Health Education"[Mesh] OR "Health Promotion"[Mesh] OR "Program 
Evaluation"[Mesh] OR "Preventive Health Services"[Mesh] OR intervention*[Title] OR program*[Title] OR risk 
reduc*[Title] OR prevent*[Title] OR educat*[Title] OR "health promotion"[Title])) Publication date from 1990/01/01; 
English
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Table 1
Characteristics of First-, Second-, and Third-Generation Women-focused Interventions for HIV Prevention 
among Women Who Use Alcohol and Other Drugs






Women’s group • • •
Male condom use skills • • •
Female condom use skills • • •
Negotiation • • •
US based • • •
Assertiveness training • • •
Sexual risk and drug use outcomes • • •
One-on-one risk reduction • • •
Cultural/ethnic tailoring • •
Sex workers • •
International focus and adaptations • •
Comorbidity, HIV-positive, distress • •
Focus on risks noninjecting • •
Criminal justice • •
Gender-based violence • •
Contextual: homelessness, employment • •
Health disparities and social determinants • •
Stigma and accessing services • •
Biomedical components(ART, microbicide, adherence) •
Note. ART=antiretroviral therapy
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